World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   317 records for 99 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
RecruitingYesCTRI/2017/03/007979
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (LixiRam)
01-03-2017
RecruitingNoNCT03066284
A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes
23/02/2017
RecruitingYesISRCTN99072045
Heliox delivered by high flow nasal cannula in infants with acute bronchiolitis
26/01/2017
AuthorisedYesEUCTR2016-001560-11-SK
Study of safety of QAW039 in patients (= 12 yrs) with asthma inadequately controlled on standard-of-care asthma therapy 12/01/2017
RecruitingYesNCT03006198
Tracking Biologics Along the Silk Road
28/12/2016
Not recruitingYesNCT02805361
Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus
09/06/2016
Not recruitingYesNCT02798315
Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study
09/06/2016
RecruitingYesNCT02792218
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-005418-31-ESStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis05/08/2016
AuthorisedEUCTR2015-005418-31-HUStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis08/07/2016
AuthorisedEUCTR2015-005418-31-DKStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis13/07/2016
AuthorisedEUCTR2015-005418-31-GRStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis05/09/2016
AuthorisedEUCTR2015-005418-31-HRStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis15/12/2016
AuthorisedEUCTR2015-005418-31-PLStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis20/09/2016
AuthorisedEUCTR2015-005418-31-NLStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis08/08/2016
AuthorisedEUCTR2015-005418-31-GBStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis11/07/2016
AuthorisedEUCTR2015-005418-31-DEStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis08/07/2016
AuthorisedEUCTR2015-005418-31-FRStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis12/01/2017
AuthorisedEUCTR2015-005418-31-SKStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis29/07/2016
AuthorisedEUCTR2015-005418-31-EEStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis10/08/2016
AuthorisedEUCTR2015-005418-31-SEStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis13/07/2016
AuthorisedEUCTR2015-005418-31-BGStudy of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosis12/08/2016
Not RecruitingCTRI/2017/03/008181Study of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing multiple sclerosis22-03-2017
02/06/2016
RecruitingYesNCT02793180
Documentation of Heart Failure in a Gulf Registry
15/05/2016
RecruitingNoNCT02791867
Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake
12/05/2016
     
1 2 3 4 5 6 7 8 9 10
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history